- Products & Services
-
Media
Media Releases - Procurement & Finance
- Research & Publications
Home
/
Research & Publications
/
Haemovigiliance
Haemovigilance
Monitoring potential adverse outcomes related to blood transfusion is key in ensuring ongoing improvement in our products and services. This is done through our Haemovigilance Program.
The International Haemovigilance Network defines haemovigilance as:
“A set of surveillance procedures covering the whole transfusion chain (from the collection of blood and its components to the follow-up of recipients), intended to collect and assess information on unexpected or undesirable effects resulting from the therapeutic use of labile blood products, and to prevent their occurrence or recurrence.”
The objectives of our Haemovigilance Program are to:
The International Haemovigilance Network defines haemovigilance as:
“A set of surveillance procedures covering the whole transfusion chain (from the collection of blood and its components to the follow-up of recipients), intended to collect and assess information on unexpected or undesirable effects resulting from the therapeutic use of labile blood products, and to prevent their occurrence or recurrence.”
The objectives of our Haemovigilance Program are to:
- Monitor adverse transfusion reactions and donor adverse events.
- Create awareness among healthcare professionals of the risks associated with blood and blood product transfusions, and blood donation.
- Generate evidence-based recommendations through the promotion of research.
- Communicate findings to all key stakeholders.
- Create national and international cooperation to promote accurate, non-biased and standardised haemovigilance reporting.
Organise a blood drive!
Help SANBS recruit new blood donors by organising a blood drive in your community,
office, school, college, church, or residential complex.